PVI
Pura Vida Investments Portfolio holdings
AUM
$16.6M
This Quarter Return
+11.44%
1 Year Return
-3.82%
3 Year Return
-0.02%
5 Year Return
+29.84%
10 Year Return
+256.58%
AUM
$394M
AUM Growth
+$394M
(+49%)
Cap. Flow
+$75.6M
Cap. Flow
% of AUM
19.19%
Top 10 Holdings %
Top 10 Hldgs %
51.76%
Holding
117
New
22
Increased
24
Reduced
6
Closed
22
Top Buys
| 1 |
VRAY
ViewRay, Inc.
VRAY
|
$23.7M |
| 2 |
IMDX
Insight Molecular Diagnostics Inc. Common Stock
IMDX
|
$12.8M |
| 3 |
INOV
Inovalon Holdings, Inc. Class A Common Stock
INOV
|
$11.9M |
| 4 |
BioCryst Pharmaceuticals
BCRX
|
$7.52M |
| 5 |
Aurinia Pharmaceuticals
AUPH
|
$5.41M |
Top Sells
| 1 |
Regeneron Pharmaceuticals
REGN
|
$11.1M |
| 2 |
Gilead Sciences
GILD
|
$9.51M |
| 3 |
Smith & Nephew
SNN
|
$8.66M |
| 4 |
Baxter International
BAX
|
$5.25M |
| 5 |
GWPH
GW Pharmaceuticals Plc American Depositary Shares
GWPH
|
$3.45M |
Sector Composition
| 1 | Healthcare | 76.41% |
| 2 | Industrials | 2.67% |
| 3 | Consumer Staples | 0.45% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
1
Inspire Medical Systems
INSP
$2.77B
| $28.5M | 2.5% | 383,640 +25,940 | +7% | +$1.93M |
|
|
NSTG
2
DELISTED
NanoString Technologies, Inc.
NSTG
| $26.8M | 2.36% | 964,570 +90,770 | +10% | +$2.53M |
|
|
VRAY
3
DELISTED
ViewRay, Inc.
VRAY
| $26.8M | 2.36% | 6,352,939 +5,617,945 | +764% | +$23.7M |
|
4
Zimmer Biomet
ZBH
$21B
| $19.6M | 1.72% | 130,790 +13,348 | +11% | +$2M |
|
5
ICU Medical
ICUI
$3.15B
| $19.3M | 1.7% | 103,320 +10,820 | +12% | +$2.02M |
|
6
STAAR Surgical
STAA
$1.36B
| $19M | 1.67% | 540,110 +36,098 | +7% | +$1.27M |
|
7
Establishment Labs
ESTA
$1.2B
| $18.9M | 1.66% | 682,600 -62,563 | -8% | -$1.73M |
|
|
XENT
8
DELISTED
Intersect ENT, Inc
XENT
| $18.2M | 1.6% | 730,360 +60,360 | +9% | +$1.5M |
|
9
Grifois
GRFS
$6.78B
| $13.5M | 1.19% | 578,620 +82,419 | +17% | +$1.92M |
|
|
AGN
10
DELISTED
Allergan plc
AGN
| $13.3M | 1.17% | 69,750 +2,641 | +4% | +$505K |
|
|
INOV
11
DELISTED
Inovalon Holdings, Inc. Class A Common Stock
INOV
| $13.3M | 1.17% | 708,470 +633,470 | +845% | +$11.9M |
|
|
IMDX
12
Insight Molecular Diagnostics Inc. Common Stock
IMDX
$72.4M
| $12.8M | 1.13% | +5,696,576 | New | +$12.8M |
|
|
IVC
13
DELISTED
Invacare Corporation
IVC
| $12.1M | 1.06% | 1,338,493 +518,619 | +63% | +$4.68M |
|
14
DexCom
DXCM
$29.5B
| $12M | 1.06% | 55,082 +10,082 | +22% | +$2.21M |
|
15
OrthoPediatrics
KIDS
$536M
| $11.4M | 1.01% | 243,392 +70,892 | +41% | +$3.33M |
|
|
RCM
16
DELISTED
R1 RCM Inc. Common Stock
RCM
| $10.5M | 0.92% | 809,610 +52,471 | +7% | +$681K |
|
|
QTNT
17
DELISTED
Quotient Limited Ordinary Shares
QTNT
| $10.4M | 0.91% | 1,090,400 +525,306 | +93% | +$5M |
|
|
ALXN
18
DELISTED
Alexion Pharmaceuticals Inc
ALXN
| $9.43M | 0.83% | 87,190 +34,690 | +66% | +$3.75M |
|
|
19
BioCryst Pharmaceuticals
BCRX
$1.74B
| $7.52M | 0.66% | +2,179,950 | New | +$7.52M |
|
20
10x Genomics
TXG
$1.74B
| $6.66M | 0.59% | 87,340 -2,660 | -3% | -$203K |
|
|
21
Aurinia Pharmaceuticals
AUPH
$1.58B
| $5.41M | 0.48% | +267,050 | New | +$5.41M |
|
22
CONMED
CNMD
$1.68B
| $5.18M | 0.46% | 46,330 -1,170 | -2% | -$131K |
|
23
Apyx Medical
APYX
$75.3M
| $4.85M | 0.43% | 573,782 +147,910 | +35% | +$1.25M |
|
24
Guardant Health
GH
$8.41B
| $4.69M | 0.41% | +59,960 | New | +$4.69M |
|
|
AXNX
25
DELISTED
Axonics, Inc. Common Stock
AXNX
| $4.53M | 0.4% | +163,490 | New | +$4.53M |
|